These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 23488777)
1. Preparation of calcium phosphate nanocapsules including simvastatin/deoxycholic acid assembly, and their therapeutic effect in osteoporosis model mice. Ito T; Takemasa M; Makino K; Otsuka M J Pharm Pharmacol; 2013 Apr; 65(4):494-502. PubMed ID: 23488777 [TBL] [Abstract][Full Text] [Related]
2. Preparation of injectable auto-forming alginate gel containing simvastatin with amorphous calcium phosphate as a controlled release medium and their therapeutic effect in osteoporosis model rat. Ito T; Saito M; Uchino T; Senna M; Iafisco M; Prat M; Rimondini L; Otsuka M J Mater Sci Mater Med; 2012 May; 23(5):1291-7. PubMed ID: 22391994 [TBL] [Abstract][Full Text] [Related]
3. Bone-targeted delivery of simvastatin-loaded PEG-PLGA micelles conjugated with tetracycline for osteoporosis treatment. Xie Y; Liu C; Huang H; Huang J; Deng A; Zou P; Tan X Drug Deliv Transl Res; 2018 Oct; 8(5):1090-1102. PubMed ID: 30027372 [TBL] [Abstract][Full Text] [Related]
4. Periostin-targeted SDSSD peptide decorated calcium phosphate nanocomposites incorporation with simvastatin for osteoporosis treatment. Pan Z; Zhang Z; Deng X; Hu F; Jia F; Lu J; Zhang X; Yang X; Gao Y; Wang X; Cui X; Xu C; Wu Y Nanotechnology; 2023 Dec; 35(7):. PubMed ID: 37976543 [TBL] [Abstract][Full Text] [Related]
5. The effectiveness of the controlled release of simvastatin from β-TCP macrosphere in the treatment of OVX mice. Chou J; Ito T; Otsuka M; Ben-Nissan B; Milthorpe B J Tissue Eng Regen Med; 2016 Mar; 10(3):E195-203. PubMed ID: 23784984 [TBL] [Abstract][Full Text] [Related]
6. Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats. Samadfam R; Awori M; Bénardeau A; Bauss F; Sebokova E; Wright M; Smith SY J Endocrinol; 2012 Feb; 212(2):179-86. PubMed ID: 22062085 [TBL] [Abstract][Full Text] [Related]
7. Application of calcium phosphate as a controlled-release device. Ito T; Otsuka M Biol Pharm Bull; 2013; 36(11):1676-82. PubMed ID: 24189411 [TBL] [Abstract][Full Text] [Related]
8. Effects of Simvastatin on bone healing around titanium implants in osteoporotic rats. Du Z; Chen J; Yan F; Xiao Y Clin Oral Implants Res; 2009 Feb; 20(2):145-50. PubMed ID: 19077150 [TBL] [Abstract][Full Text] [Related]
9. Preparation and properties of biocompatible PS-PEG/calcium phosphate nanospheres. Wang Q; Liu P; Sun Y; Gong T; Zhu M; Sun X; Zhang Z; Duan Y Nanotoxicology; 2015 Mar; 9(2):190-200. PubMed ID: 24787691 [TBL] [Abstract][Full Text] [Related]
10. Dissolution medium responsive simvastatin release from biodegradable apatite cements and the therapeutic effect in osteoporosis rats. Hamada H; Ohshima H; Otsuka M J Appl Biomater Funct Mater; 2012 Jun; 10(1):22-8. PubMed ID: 22367687 [TBL] [Abstract][Full Text] [Related]
11. Simvastatin prodrug micelles target fracture and improve healing. Jia Z; Zhang Y; Chen YH; Dusad A; Yuan H; Ren K; Li F; Fehringer EV; Purdue PE; Goldring SR; Daluiski A; Wang D J Control Release; 2015 Feb; 200():23-34. PubMed ID: 25542644 [TBL] [Abstract][Full Text] [Related]
12. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles. Min KH; Lee HJ; Kim K; Kwon IC; Jeong SY; Lee SC Biomaterials; 2012 Aug; 33(23):5788-97. PubMed ID: 22591612 [TBL] [Abstract][Full Text] [Related]
13. In situ fabrication of alendronate-loaded calcium phosphate microspheres: controlled release for inhibition of osteoclastogenesis. Kim CW; Yun YP; Lee HJ; Hwang YS; Kwon IK; Lee SC J Control Release; 2010 Oct; 147(1):45-53. PubMed ID: 20600398 [TBL] [Abstract][Full Text] [Related]
14. The ovariectomized, mature rat model of postmenopausal osteoporosis: an assessment of the bone sparing effects of curcumin. French DL; Muir JM; Webber CE Phytomedicine; 2008 Dec; 15(12):1069-78. PubMed ID: 18693096 [TBL] [Abstract][Full Text] [Related]
15. The Evaluation of Therapeutic Efficacy and Safety Profile of Simvastatin Prodrug Micelles in a Closed Fracture Mouse Model. Zhang Y; Jia Z; Yuan H; Dusad A; Ren K; Wei X; Fehringer EV; Purdue PE; Daluiski A; Goldring SR; Wang D Pharm Res; 2016 Aug; 33(8):1959-71. PubMed ID: 27164897 [TBL] [Abstract][Full Text] [Related]
16. Anabolic therapies for osteoporosis. Uihlein AV; Leder BZ Endocrinol Metab Clin North Am; 2012 Sep; 41(3):507-25. PubMed ID: 22877427 [TBL] [Abstract][Full Text] [Related]
17. Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women. Rejnmark L; Buus NH; Vestergaard P; Heickendorff L; Andreasen F; Larsen ML; Mosekilde L J Bone Miner Res; 2004 May; 19(5):737-44. PubMed ID: 15068496 [TBL] [Abstract][Full Text] [Related]
18. Simvastatin-loaded macroporous calcium phosphate cement: preparation, in vitro characterization, and evaluation of in vivo performance. Yin H; Li YG; Si M; Li JM J Biomed Mater Res A; 2012 Nov; 100(11):2991-3000. PubMed ID: 22700467 [TBL] [Abstract][Full Text] [Related]
19. Simvastatin-loaded β-TCP drug delivery system induces bone formation and prevents rhabdomyolysis in OVX mice. Chou J; Ito T; Otsuka M; Ben-Nissan B; Milthorpe B Adv Healthc Mater; 2013 May; 2(5):678-81. PubMed ID: 23184712 [TBL] [Abstract][Full Text] [Related]